Back to search results

Improving Memory, Sleep, and Well-being for Older Adults

This study is testing if adding a Memory Support Intervention (MSI) to a Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) can better improve sleep, daily functioning, and overall well-being for people aged 50 and older. You might be eligible if you are 50 or older, speak English, have a mobility impairment, low income, and experience sleep or circadian (your body's natural sleep-wake cycle) problems. Researchers will measure changes in your sleep, how well you function day-to-day, and your satisfaction with life over time. The study's current status is unclear.

Study design
This interventional study plans to enroll 178 participants aged 50 and older. Participants will be randomly assigned to receive either TranS-C plus MSI or TranS-C alone.
What's involved
You would attend eight weekly, 50-minute individual sessions. Assessments will be done at the start, after treatment (8-10 weeks), and then at 6 and 12 months after treatment.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 12 months after the end of treatment, with assessments at 6 and 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05986604

NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment

Recruiting
NAAges 50+InterventionalTreatment
University of California, Berkeley
~178 participants
Updated 2025-11-24 on ClinicalTrials.gov
What's tested:Memory Support InterventionTransdiagnostic Intervention for Sleep and Circadian Dysfunction

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient-Reported Outcomes Measurement Information System - Sleep Disturbance
Measured over Change from baseline to post-treatment, which is 8-10 weeks after the beginning of treatment to 6-month follow-up to 12-month follow-up
+2 more outcomes measured

Conditions

Sleep Disorder
Circadian Dysregulation
Memory Impairment

Explore related trials

Circadian dysregulationMemory ImpairmentSleep Disorder

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Allison Harvey, PhD · PRINCIPAL_INVESTIGATOR · University of California, Berkeley

Who to contact

Allison Harvey, PhD
[email protected]
5106427138
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • Patient-Reported Outcomes Measurement Information System - Sleep DisturbanceChange from baseline to post-treatment, which is 8-10 weeks after the beginning of treatment to 6-month follow-up to 12-month follow-up

    Assesses perceived functional impairments related to sleep problems using a self-report questionnaire. The minimum value is 8. The maximum value is 40. Higher scores mean more sleep disturbance (worse outcome).

  • Sheehan Disability ScaleChange from baseline to post-treatment, which is 8-10 weeks after the beginning of treatment to 6-month follow-up to 12-month follow-up

    Assesses functional impairment on a scale from 0 to 30, where higher scores mean higher impairment

  • Satisfaction with Life ScaleChange from baseline to post-treatment, which is 8-10 weeks after the beginning of treatment to 6-month follow-up to 12-month follow-up

    5-item instrument designed to measure global cognitive judgements of satisfaction with one's life. Scores can range from 5-35 with higher scores indicating higher levels of satisfaction with life.